33.93
前日終値:
$34.44
開ける:
$34
24時間の取引高:
1.16M
Relative Volume:
1.60
時価総額:
$1.26B
収益:
$154.15M
当期純損益:
$-33.58M
株価収益率:
-35.34
EPS:
-0.96
ネットキャッシュフロー:
$-20.74M
1週間 パフォーマンス:
-10.17%
1か月 パフォーマンス:
-19.01%
6か月 パフォーマンス:
+37.98%
1年 パフォーマンス:
-32.02%
Harrow Inc Stock (HROW) Company Profile
HROW を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
HROW
Harrow Inc
|
33.93 | 1.27B | 154.15M | -33.58M | -20.74M | -0.96 |
|
ZTS
Zoetis Inc
|
120.24 | 52.69B | 9.40B | 2.65B | 2.22B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.66 | 43.09B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.46 | 41.90B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
23.97 | 28.06B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
448.91 | 19.55B | 3.08B | 1.24B | 1.07B | 25.61 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-06-12 | 開始されました | BTIG Research | Buy |
| 2025-06-10 | 開始されました | William Blair | Outperform |
| 2025-02-06 | 開始されました | H.C. Wainwright | Buy |
| 2024-12-04 | 繰り返されました | B. Riley Securities | Buy |
| 2024-04-11 | 開始されました | Craig Hallum | Buy |
| 2022-09-08 | 再開されました | B. Riley Securities | Buy |
| 2021-10-14 | 再開されました | B. Riley Securities | Buy |
| 2021-09-24 | 開始されました | Aegis Capital | Buy |
| 2021-07-02 | 開始されました | Ladenburg Thalmann | Buy |
すべてを表示
Harrow Inc (HROW) 最新ニュース
Custom watchlist performance reports with Harrow Inc.Weekly Gains Summary & Verified Technical Signals - newser.com
Should you hold or exit Harrow Inc. nowJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
How Harrow Inc. stock reacts to job market dataWeekly Trend Report & Safe Swing Trade Setups - newser.com
What insider trading reveals about Harrow Inc. stockTrade Performance Summary & Consistent Profit Focused Trading Strategies - newser.com
Best data tools to analyze Harrow Inc. stockInsider Buying & Free Verified High Yield Trade Plans - newser.com
Detecting price anomalies in Harrow Inc. with AI2025 Valuation Update & Community Supported Trade Ideas - newser.com
Can Harrow Inc. stock sustain market leadership2025 Market Overview & Growth Focused Investment Plans - newser.com
Harrow Inc. stock volume spike explainedWeekly Profit Recap & AI Driven Price Forecasts - newser.com
Is Harrow Inc. stock supported by strong cash flowsIPO Watch & Weekly Momentum Picks - fcp.pa.gov.br
What is the fair value of Harrow Inc. stock nowBond Market & Growth-Oriented Investment Plans - newser.com
Will Harrow Inc. stock return to pre crisis levelsJuly 2025 Momentum & AI Optimized Trade Strategies - fcp.pa.gov.br
Why Harrow Inc. stock is in analyst buy zoneWeekly Investment Summary & Free Long-Term Investment Growth Plans - newser.com
Will Harrow Inc. stock pay special dividends2025 Market Outlook & Risk Managed Investment Strategies - newser.com
Harrow Q3 Earnings Preview: This Business Has Eye-Popping Potential (NASDAQ:HROW) - Seeking Alpha
How Harrow Inc. stock reacts to global recession fearsProduct Launch & Comprehensive Market Scan Reports - newser.com
While Harrow (NASDAQ:HROW) Shareholders Have Made 480% in 5 Years, Increasing Losses Might Now Be Front of Mind as Stock Sheds 5.7% This Week - 富途牛牛
Harrow (HROW) Expected to Announce Earnings on Monday - MarketBeat
Analyzing Harrow Inc. with risk reward ratio chartsDividend Hike & Low Risk Investment Opportunities - newser.com
What risks investors should watch in Harrow Inc. stock2025 Retail Activity & High Accuracy Swing Entry Alerts - newser.com
Westside Investment Management Inc. Raises Stake in Harrow, Inc. $HROW - MarketBeat
Key resistance and support levels for Harrow Inc.July 2025 Snapshot & Daily Risk Controlled Trade Plans - newser.com
Harrow, Inc. (HROW) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Harrow Inc (HROW) 財務データ
収益
当期純利益
現金流量
EPS
Harrow Inc (HROW) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Jun 10 '25 |
Sale |
30.80 |
15,000 |
462,033 |
90,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 09 '25 |
Sale |
30.37 |
15,204 |
461,794 |
105,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 03 '25 |
Sale |
30.04 |
3,000 |
90,116 |
122,000 |
| Opaleye Management Inc. | 10% Owner |
Jun 04 '25 |
Sale |
30.02 |
1,796 |
53,907 |
120,204 |
| Opaleye Management Inc. | 10% Owner |
May 12 '25 |
Sale |
25.90 |
10,000 |
258,959 |
130,000 |
| Opaleye Management Inc. | 10% Owner |
May 13 '25 |
Sale |
26.59 |
5,000 |
132,945 |
125,000 |
| BOLL ANDREW R. | Chief Financial Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
346,500 |
0 |
914,589 |
| SAHAREK JOHN P. | CEO & President, ImprimisRx |
Apr 03 '25 |
Option Exercise |
0.00 |
277,200 |
0 |
576,863 |
| BAUM MARK L | Chief Executive Officer |
Apr 03 '25 |
Option Exercise |
0.00 |
762,300 |
0 |
2,899,825 |
| Opaleye Management Inc. | 10% Owner |
Mar 18 '25 |
Sale |
30.01 |
5,000 |
150,055 |
140,000 |
大文字化:
|
ボリューム (24 時間):